Avid Bioservices Inc (CDMO)

[pphmtoolong]

Since we enjoy reliving the past, let's focus on the amazing good fortune that Peregrine has enjoyed. The company's first two major thrusts fell short of success for whatever reason, i.e. Oncolym and Cotara. Both probably decent products, but just not quite good enough.

Then who comes along? Doctor Phil Thorpe, may he rest in peace. A huge stroke of luck for Peregrine.

Then, on his way to discover a way to attack tumor vasculature, remember how avastin and anti-angiogenesis used to be the rage, he uncovers the immune evading phosphatylserine of cancers and viruses.

Then amazingly enough his anti tumor vasculature MAB, Bavituximab, turns out to be an anti-PS MAB.

Then, it turns out that in clinical trials Bavi actually has significant anti-tumor and anti-virus effects. Now we have Bavi in a highly promising Phase III trial

I know some focus and refocus on Peregrine's missteps, but it amazes me how little attention is focused on the incredible good luck the obscure Tustin firm has enjoyed.

GLTA, Paul